Peking University First Hospital: Acute Kidney Injury trials
The registry lists 14 Acute Kidney Injury studies with Peking University First Hospital as lead sponsor. 4 are open to participants now and 0 have results posted.
Phase 2 1Phase 3 1No phase 13(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Novel Biomarkers and Postoperative Kidney Injury in Radical NephrectomyRecruitingNCT07088874
- Development and Validation of a Real-time Prediction Model for Acute Kidney Injury in Hospitalized PatientsRecruitingNCT06597838
- Goal-directed Hemodynamic Management and Kidney Injury After Radical Nephrectomy or NephroureterectomyRecruitingNCT05149196Not applicable
- Targeted Blood-pressure Management and Acute Kidney Injury After Coronary Artery Bypass SurgeryRecruitingNCT03629418Not applicable
- Risk Factors of Postoperative Acute Kidney Injury and Mortality Among Hospitalized Patients Undergoing Major SurgeryCompletedNCT07136194
- Effect of Urine-guided Hydration on Acute Kidney Injury After CRS-HIPECCompletedNCT05939193Not applicable
- Effect of Cholesterol Level on Postoperative Acute Kidney Injury of Non-cardiac SurgeriesCompletedNCT03954353
- Intraoperative Hypotension and Acute Kidney Injury After Off-pump Coronary Artery Bypass Grafting SurgeryCompletedNCT03889730
- Preoperative Serum Albumin and Duration of Intraoperative Hypotension on Postoperative Acute Kidney InjuryCompletedNCT03882658
- Early Prediction of Acute Kidney Injury in High Risk Patients After Non-cardiac SurgeryStatus unknownNCT03880110
- Vancomycin-Associated Acute Kidney Injury: A Cross-Sectional Study From a Multi- Center in ChinaStatus unknownNCT03456544
- Intensive Versus Regular Dosage For PD In AKI.TerminatedNCT03438877Not applicable
- Circulatory Management and Acute Kidney Injury in Patients Undergoing Partial NephrectomyCompletedNCT02803372Not applicable
- Trial of Plasma Exchange for Severe Crescentic IgA NephropathyTerminatedNCT02647255Phase 2/3